Interleukin-9 regulates NF-kappaB activity through BCL3 gene induction

Area of Science:

• Immunology
• Molecular Biology
• Cell Signaling

Background:

• BCL3 protein shares homology with IkappaB proteins and interacts with p50 NF-kappaB homodimers.
• The precise regulation and transcriptional activity of BCL3 remain incompletely understood.
• NF-kappaB signaling is crucial in immune responses but its upstream regulation is complex.

Purpose of the Study:

• To elucidate the regulatory mechanisms controlling BCL3 gene expression.
• To investigate the role of interleukins, specifically IL-9, in BCL3 regulation.
• To understand how BCL3 influences NF-kappaB transcriptional activity.

Main Methods:

• Quantitative analysis of BCL3 mRNA expression in T cells and mast cells following cytokine stimulation.
• Investigation of the involvement of the Jak/STAT pathway in IL-9-induced BCL3 upregulation.
• Assessing p50 homodimer DNA binding activity and NF-kappaB-mediated transcription.
• Comparative analysis with TNF-alpha-induced NF-kappaB activation.

Main Results:

• Interleukin-9 (IL-9) and IL-4, but not IL-2 or IL-3, transcriptionally upregulated BCL3 expression in T cells and mast cells.
• IL-9-induced BCL3 expression was rapid (4 hours) and dependent on the Jak/STAT pathway.
• IL-9 stimulation increased p50 homodimer DNA binding activity, an effect mimicked by BCL3 overexpression.
• IL-9 or BCL3 transfection inhibited TNF-alpha-induced NF-kappaB transcription.

Conclusions:

• A novel regulatory pathway for NF-kappaB transcription factors exists, involving STAT-dependent upregulation of BCL3 by IL-9.
• BCL3 acts as a modulator of NF-kappaB activity, distinct from canonical IkappaB-mediated regulation.
• This finding provides new insights into the intricate network controlling immune cell responses.